274 related articles for article (PubMed ID: 15151516)
41. Effectiveness of azelastine nasal spray compared with oral cetirizine in patients with seasonal allergic rhinitis.
Corren J; Storms W; Bernstein J; Berger W; Nayak A; Sacks H;
Clin Ther; 2005 May; 27(5):543-53. PubMed ID: 15978303
[TBL] [Abstract][Full Text] [Related]
42. Randomized placebo-controlled trial comparing montelukast and cetirizine for treating perennial allergic rhinitis in children aged 2-6 yr.
Chen ST; Lu KH; Sun HL; Chang WT; Lue KH; Chou MC
Pediatr Allergy Immunol; 2006 Feb; 17(1):49-54. PubMed ID: 16426255
[TBL] [Abstract][Full Text] [Related]
43. A double-blind, placebo-controlled trial of montelukast in adult atopic eczema.
Friedmann PS; Palmer R; Tan E; Ogboli M; Barclay G; Hotchkiss K; Berth-Jones J
Clin Exp Allergy; 2007 Oct; 37(10):1536-40. PubMed ID: 17850382
[TBL] [Abstract][Full Text] [Related]
44. The effects of histamine and leukotriene receptor antagonism on nasal mannitol challenge in allergic rhinitis.
Lee DK; Haggart K; Currie GP; Anderson SD; Lipworth BJ
Br J Clin Pharmacol; 2003 Jun; 55(6):639-42. PubMed ID: 12814463
[TBL] [Abstract][Full Text] [Related]
45. Comparison of montelukast and fexofenadine for chronic idiopathic urticaria.
Nettis E; Dambra P; D'Oronzio L; Loria MP; Ferrannini A; Tursi A
Arch Dermatol; 2001 Jan; 137(1):99-100. PubMed ID: 11176678
[No Abstract] [Full Text] [Related]
46. Levocetirizine improves nasal symptoms and airflow in patients with persistent allergic rhinitis: a pilot study.
Ciprandi G; Cirillo IG; Vizzaccaro A; Tosca MA
Eur Ann Allergy Clin Immunol; 2005 Jan; 37(1):25-9. PubMed ID: 15745374
[TBL] [Abstract][Full Text] [Related]
47. Montelukast protects against nasal lysine-aspirin challenge in patients with aspirin-induced asthma.
Lee DK; Haggart K; Robb FM; Lipworth BJ
Eur Respir J; 2004 Aug; 24(2):226-30. PubMed ID: 15332389
[TBL] [Abstract][Full Text] [Related]
48. The effect of montelukast on wheal reactions in skin prick tests: a double-blind-placebo-controlled randomized trial.
Bulan K; Aydogan M; Siraneci R; Aydogmus CY
Int J Pediatr Otorhinolaryngol; 2013 Oct; 77(10):1655-8. PubMed ID: 23958393
[TBL] [Abstract][Full Text] [Related]
49. A 12-week placebo-controlled study of rupatadine 10 mg once daily compared with cetirizine 10 mg once daily, in the treatment of persistent allergic rhinitis.
Fantin S; Maspero J; Bisbal C; Agache I; Donado E; Borja J; Mola O; Izquierdo I;
Allergy; 2008 Jul; 63(7):924-31. PubMed ID: 18588560
[TBL] [Abstract][Full Text] [Related]
50. Montelukast (Singulair) for perennial allergic rhinitis.
Obstet Gynecol; 2006 Apr; 107(4):943-4. PubMed ID: 16582136
[No Abstract] [Full Text] [Related]
51. Pharmacotherapy for allergic rhinitis: a critical review of leukotriene receptor antagonists compared with other treatments.
Nathan RA
Ann Allergy Asthma Immunol; 2003 Feb; 90(2):182-90; quiz 190-1, 232. PubMed ID: 12602664
[TBL] [Abstract][Full Text] [Related]
52. Efficacy and safety of bilastine 20 mg compared with cetirizine 10 mg and placebo for the symptomatic treatment of seasonal allergic rhinitis: a randomized, double-blind, parallel-group study.
Kuna P; Bachert C; Nowacki Z; van Cauwenberge P; Agache I; Fouquert L; Roger A; Sologuren A; Valiente R;
Clin Exp Allergy; 2009 Sep; 39(9):1338-47. PubMed ID: 19438584
[TBL] [Abstract][Full Text] [Related]
53. Levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria in adults and children.
Singh-Franco D; Ghin HL; Robles GI; Borja-Hart N; Perez A
Clin Ther; 2009 Aug; 31(8):1664-87. PubMed ID: 19808127
[TBL] [Abstract][Full Text] [Related]
54. Montelukast is not effective in controlling allergic symptoms outside the airways: a randomised double-blind placebo-controlled crossover study.
Lehtimäki L; Petäys T; Haahtela T
Int Arch Allergy Immunol; 2009; 149(2):150-3. PubMed ID: 19127072
[TBL] [Abstract][Full Text] [Related]
55. Decongestant effects of nasal xylometazoline and mometasone furoate in persistent allergic rhinitis.
Barnes ML; Biallosterski BT; Gray RD; Fardon TC; Lipworth BJ
Rhinology; 2005 Dec; 43(4):291-5. PubMed ID: 16405274
[TBL] [Abstract][Full Text] [Related]
56. Fexofenadine decreases sensitivity to and montelukast improves recovery from inhaled mannitol.
Brannan JD; Anderson SD; Gomes K; King GG; Chan HK; Seale JP
Am J Respir Crit Care Med; 2001 May; 163(6):1420-5. PubMed ID: 11371412
[TBL] [Abstract][Full Text] [Related]
57. Clinical studies of the DP1 antagonist laropiprant in asthma and allergic rhinitis.
Philip G; van Adelsberg J; Loeys T; Liu N; Wong P; Lai E; Dass SB; Reiss TF
J Allergy Clin Immunol; 2009 Nov; 124(5):942-8.e1-9. PubMed ID: 19748656
[TBL] [Abstract][Full Text] [Related]
58. Effects of levocetirizine as add-on therapy to fluticasone in seasonal allergic rhinitis.
Barnes ML; Ward JH; Fardon TC; Lipworth BJ
Clin Exp Allergy; 2006 May; 36(5):676-84. PubMed ID: 16650054
[TBL] [Abstract][Full Text] [Related]
59. Safety and efficacy of oral fexofenadine in children with seasonal allergic rhinitis--a pooled analysis of three studies.
Meltzer EO; Scheinmann P; Rosado Pinto JE; Bachert C; Hedlin G; Wahn U; Finn AF; Ruuth E
Pediatr Allergy Immunol; 2004 Jun; 15(3):253-60. PubMed ID: 15209959
[TBL] [Abstract][Full Text] [Related]
60. Nasal eosinophilia and serum soluble intercellular adhesion molecule 1 in patients with allergic rhinitis treated with montelukast alone or in combination with desloratadine or levocetirizine.
Ciebiada M; Barylski M; Gorska Ciebiada M
Am J Rhinol Allergy; 2013; 27(2):e58-62. PubMed ID: 23562192
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]